Dr. Fabian Kausche Joins FidoCure Advisory Board
Leading Animal Health Expert Dr. Fabian Kausche Joins FidoCure Advisory Board
Celebrating 5 Years of Research at AACR
FidoCure by the One Health Company and Stanford University Research Shared at AACR 2024
Interview with Renowned Oncologist and Former FDA Leader Amy Abernethy
Top Downloaded Cancer Paper in 2023
Read More
Adrenocortical Carcinoma Case Study: Pixelle
History and Initial Treatment
Pixelle, a 13 year old Shih Tzu, started her long cancer journey in June of 2020 when she was diagnosed with a left-sided adrenal mass after undergoing a thorough workup for vomiting, polyuria/polydipsia, and intermittent urinary incontinence. A pheochromocytoma was ruled out as a low-dose dexamethasone suppression test was consistent with Cushing’s Disease (cortisol secreting tumor).
Precision Medicine in Veterinary Science: Veterinary Clinics of North America
Revolutionizing Veterinary Oncology: Precision Medicine Paves the Way for Personalized Cancer Treatment in Dogs
A Year of Breakthroughs: A look back at 2023
We would like to express our heartfelt gratitude to our veterinary community as we come to the close of the year. Together, we have made a tremendous impact by enabling precision medicine to nearly 5,000 pet dogs battling cancer.
Innovative Bioinformatics Pipeline Reduces Costs and Expands Access to Precision Therapeutics for Canine Oncology
Today we would like to share another exciting development in the field of canine oncology genetics and precision therapeutics from our manuscript "Shared Hotspot Mutations in Oncogenes Position Dogs as an Unparalleled Comparative Model for Precision Therapeutics," recently published in Scientific Reports.
Canine Cancer Osteosarcoma Research
In our relentless pursuit of advancements in veterinary oncology, the FidoCure Team's research has taken center stage, offering an in-depth exploration into the realm of canine osteosarcoma. The use of real-world data and machine learning techniques promises to provide invaluable insights into the mutation patterns and treatment outcomes associated with this challenging condition.
Mammary Carcinoma: Insights from BRCA1 mutations
Genetic Signatures in Canine Mammary Tumors: insights from BRCA1 mutations
